Noopept Powder: molecular data, studies & sources

Molecular formula, weight & structure

Molecular formula (MF)

C17H22N2O4

Molecular weight (MW)

318.4 g/mol

PubChem compound ID

180496

Record title

1-(2-Phenylacetyl)-L-prolylglycine ethy ester

Values describe the selected PubChem molecular entity. Counterions, salt forms, hydration and sequence changes can alter the supplied material. Confirm the exact identity against the supplier specification.

Source: PubChem CID 180496 · retrieved 2026-09-21

Registered clinical trials

Studies registered on ClinicalTrials.gov that list Noopept as an intervention. Studies that only measure the molecule as a biomarker, or use it only as a comparator or background arm for another drug, are excluded. A registration describes a planned or completed protocol; it does not report a result. Active studies are listed first.

No registered study naming this compound was matched. This is a documented gap in registry coverage, not proof that no study exists.

Registry check 2026-10-01 · Run this search on ClinicalTrials.gov

Human intervention studies

Selected studies in which participants received Noopept, with their indexed or reviewed study type. Check the original article for the formulation, population and controls. Studies that only measured the molecule, or used it as a comparator, are listed separately below and are not counted as intervention studies.

1. Human study · PubMed trial index Compound given to participants

   [Clinical and electroencephalographic characteristic of noopept in patients with mild cognitive impairment of posttraumatic and vascular origin].

   Bochkarev VK, Teleshova ES, Siuniakov SA et al. · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2008

   PMID 19008801

2. Human study · PubMed trial index Compound given to participants

   [Noopept in the treatment of mild cognitive impairment in patients with stroke].

   Amelin AV, Iliukhina AIu, Shmonin AA et al. · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2011

   PMID 22500312

Preclinical research, reviews & other publications

Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.

1. Preclinical / laboratory research

   Effects of noopept on cognitive functions and pubertal process in rats with diabetes.

   Gürbüz P, Düzova H, Yildiz A et al. · Life sciences · 2019

   PMID 31356906 · DOI: 10.1016/j.lfs.2019.116698

2. Review · secondary evidence

   [The original novel nootropic and neuroprotective agent noopept].

   Ostrovskaia RU, Gudasheva TA, Voronina TA et al. · Eksperimental'naia i klinicheskaia farmakologiia · 2002

   PMID 12596521

3. Research publication · design requires review

   Cognitive Enhancer Noopept Activates Transcription Factor HIF-1.

   Zainullina LF, Ivanova TV, Sadovnikov SV et al. · Doklady. Biochemistry and biophysics · 2020

   PMID 33119829 · DOI: 10.1134/S1607672920050129

4. Preclinical / laboratory research

   Noopept normalizes parameters of the incretin system in rats with experimental diabetes.

   Ostrovskaya RU, Zolotov NN, Ozerova IV et al. · Bulletin of experimental biology and medicine · 2014

   PMID 25065315 · DOI: 10.1007/s10517-014-2562-5

Noopept Powder supplier sources

Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.

Noopept Powder for sale: compare prices, sizes and forms from every tracked supplier →

Reference sources & further reading

• PubChem compound record 180496 — chemical identity and structure.
• FDA Global Substance Registration System: UNII 4QBJ98683M — substance identity, names and codes.
• Wikipedia: Omberacetam — Background encyclopedia; not a primary clinical source.

The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.

Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.

Related research profiles